Journals / Türk Dermatoloji Dergisi / 2019 / Cilt: 13 - Sayı: 1

Squamous Cell Carcinoma of the Hand: Clinical Presentation, Surgical Treatment, Outcome and Survival Rate: a Series of 129 Cases

Pages
30–34
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Tumors smaller than 2 cm had a recurrence rate of 9.7% and a metastatic rate of 6.5%; tumors larger than 2 cm had a recurrence rate of 16.7% and a metastatic rate of 33% during 5-year follow-ups.Conclusion: In contrast to squamous cell carcinoma of the face, those occurring on the hand are malignancies with a worse clinical course, greater tendency for recurrence, metastatic spread, and functional deficiency which might require amputation and complex soft tissue reconstruction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Despite its relative high frequency; the recurrence, metastasis and long-term survival rates of hand squamous cell carcinoma have not been well defined.
📊
Key Findings & Data:The aim of this study was to review a large cohort of patients with hand squamous cell carcinomas and to evaluate the management techniques, outcomes of treatment modalities and survival rates.Methods: A retrospective review of all surgically excised primary squamous cell carcinoma of the hand operated between 2006 and 2011 was included in this multi-center study.
💡
Conclusion & Impact:Tumors smaller than 2 cm had a recurrence rate of 9.7% and a metastatic rate of 6.5%; tumors larger than 2 cm had a recurrence rate of 16.7% and a metastatic rate of 33% during 5-year follow-ups.Conclusion: In contrast to squamous cell carcinoma of the face, those occurring on the hand are malignancies with a worse clinical course, greater tendency for recurrence, metastatic spread, and functional deficiency which might require amputation and complex soft tissue reconstruction.
🔬Design:Review & Systematic Survey
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Despite its relative high frequency; the recurrence, metastasis and long-term survival rates of hand squamous cell carcinoma have not been well defined. The aim of this study was to review a large cohort of patients with hand squamous cell carcinomas and to evaluate the management techniques, outcomes of treatment modalities and survival rates.Methods: A retrospective review of all surgically excised primary squamous cell carcinoma of the hand operated between 2006 and 2011 was included in this multi-center study. Patients were evaluated regarding age, anatomic location of the tumor, gender, treatment modality, survival, and recurrence rate. In addition, recurrence and survival rates were also categorized according to the tumor size.Results: A total of 129 patients were evaluated. Tumors smaller than 2 cm had a recurrence rate of 9.7% and a metastatic rate of 6.5%; tumors larger than 2 cm had a recurrence rate of 16.7% and a metastatic rate of 33% during 5-year follow-ups.Conclusion: In contrast to squamous cell carcinoma of the face, those occurring on the hand are malignancies with a worse clinical course, greater tendency for recurrence, metastatic spread, and functional deficiency which might require amputation and complex soft tissue reconstruction.

🔖

Cite This Article

IRMAK, F., ŞİRVAN, S. S., SEVİM, K. Z., YEŞİLADA, A. K., SERİN, M., YAZAR, S. K. (2019). Squamous Cell Carcinoma of the Hand: Clinical Presentation, Surgical Treatment, Outcome and Survival Rate: a Series of 129 Cases. Türk Dermatoloji Dergisi, Cilt: 13 - Sayı: 1, 30–34. https://ajindex.com/articles/409127

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. TerKonda SP, Perdikis G. Non-melanotic skin tumors of the upper extremity. Hand Clinics 2004;20:293-301
  2. Clayman GL, Lee JJ, Holsinger FC, et al. Mortality Risk From Squamous Cell Skin Cancer. Journal of Clinical Oncology 2005;23:759-65
  3. Martinez J-C, Otley CC. The Management of Melanoma and Nonmelanoma Skin Cancer: A Review for the Primary Care Physician. Mayo Clinic Proceedings 2001;76:1253-65
  4. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. British Journal of Dermatology 2002;146:18-25
  5. Bean DJ, Rees RS, O’Leary JP, et al. Carcinoma of the Hand: A 20-Year Experience. Southern Medical Journal 1984;77:998-1000
  6. Chakrabarti I, Watson JD, Dorrance H. Skin Tumours of the Hand. Journal of Hand Surgery 1993;18:484-6
  7. S. A. Benign and malignant soft tissue tumors of the hand. In: McCarthy JG MJ, Littler JW editor. Plastic Surgery. Vol 8. Philadelphia: WB Saunders; 1990. p. 5483-509
  8. Schiavon M, Mazzoleni F, Chiarelli A, et al. Squamous cell carcinoma of the hand: Fifty-five case reports. J Hand Surg Am 1988;13:401-4
  9. Henderson MM, Neumeister MW, Bueno RA. Hand Tumors. Plastic and Reconstructive Surgery 2014;133:154e-64e
  10. Maruyama H, Tanaka R, Fujisawa Y, et al. Availability of sentinel lymph node biopsy for cutaneous squamous cell carcinoma. J Dermatol 2016;44:431-7
  11. Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol 1992;26:976-90
  12. Maciburko SJ, Townley WA, Hollowood K, et al. Skin cancers of the hand: a series of 541 malignancies. Plast Reconstr Surg 2012;129:1329-36
  13. Rayner CRW. The Results of Treatment of two Hundred and Seventy-Three Carcinomas of the Hand. Hand 1981;os-13:183-6
  14. Labow BI, Greene AK, Upton J, et al. Soft Tissue Sarcomas of the Hand: Functional Reconstruction and Outcome Analysis. HAND 2008;3:229-36.